Evidence map›Paper›PMID 32143829›Full record

ArticleBiological psychiatry2020

Gene Expression in Patient-Derived Neural Progenitors Implicates WNT5A Signaling in the Etiology of Schizophrenia.

Oleg V Evgrafov, Chris Armoskus, Bozena B Wrobel, Valeria N Spitsyna, Tade Souaiaia, Jennifer S Herstein, Christopher P Walker, Joseph D Nguyen, Adrian Camarena, Jonathan R Weitz and 9 more

Open access · greenAbstract read
In one paragraph

Article in Biological psychiatry, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 1 pooled it
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 1 synthesis or guideline pooled it, 35 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Wnt/β-catenin Signaling in Central Nervous System Regeneration.Advances in experimental medicine and biology · 2025
    Review
  7. Article
  8. Altered PLCβ/IPBiomedicines · 2024
    Article
  9. Article
  10. Unraveling the Link between Olfactory Deficits and Neuropsychiatric Disorders.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Oleg V EvgrafovCollege of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York. Electronic address: oleg.evgrafov@downstate.edu.
Chris ArmoskusZilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California.
Bozena B WrobelCaruso Department of Otolaryngology, Head and Neck Surgery, Keck School of Medicine, University of Southern California, Los Angeles, California.
Valeria N SpitsynaZilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California.
Tade SouaiaiaCollege of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York.
Jennifer S HersteinDepartment of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.
Christopher P WalkerDepartment of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.
Joseph D NguyenDepartment of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.
Adrian CamarenaDepartment of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.
Jonathan R WeitzDepartment of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.
Jae Mun Hugo KimZilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California.
Edder Lopez DuarteZilkha Neurogenetic Institute, Keck School of Medicine, University of Southern California, Los Angeles, California.
Kai WangRaymond G. Perelman Center for Cellular and Molecular Therapeutics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
George M SimpsonDepartment of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.
Janet L SobellDepartment of Psychiatry and the Behavioral Sciences, Keck School of Medicine, University of Southern California, Los Angeles, California.
Helena MedeirosCollege of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York.
Michele T PatoCollege of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York.
Carlos N PatoCollege of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York.
James A KnowlesCollege of Medicine, SUNY Downstate Health Sciences University, Brooklyn, New York.
University of Southern California · USSUNY Downstate Health Sciences University · USChildren's Hospital of Philadelphia · US

Funding

African Ancestry Genomic Psychiatry CohortR01MH104964 · NIMH · SUNY DOWNSTATE MEDICAL CENTER · PI BIGDELI, TIM BERNARD, FANOUS, AYMAN H · 2015 to 2024
$16.7M
Genomic Psychiatry CohortR01MH085548 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI PATO, CARLOS N, PATO, MICHELE T · 2008 to 2012
$16.3M
Latino Ancestry Genomic Psychiatry CohortR01MH123451 · NIMH · SUNY DOWNSTATE MEDICAL CENTER · PI BIGDELI, TIM BERNARD, FANOUS, AYMAN H · 2020 to 2025
$7.1M
TRANSCRIPTOME SEQUENCING OF NEURONAL CELL LINES FROM PATIENTS WITH SCHIZOPHRENIAR01MH086874 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI EVGRAFOV, OLEG V · 2011 to 2015
$3.4M
Discovery of Genetic Variation Influencing Schizophrenia Using Next Generation DNR01MH086873 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI KNOWLES, JAMES A · 2010 to 2014
$3.3M
The USC PsychENCODE ProjectU01MH103346 · NIMH · UNIVERSITY OF SOUTHERN CALIFORNIA · PI FARNHAM, PEGGY J, KNOWLES, JAMES A · 2014 to 2017
$2.4M
NIMH NIH HHS R01 MH085548NIMH NIH HHS R01 MH086873NIMH NIH HHS R01 MH086874NIMH NIH HHS R01 MH104964NIMH NIH HHS R01 MH123451NIMH NIH HHS U01 MH103346
6 · The paper itself

Abstract

backgroundGenome-wide association studies of schizophrenia have demonstrated that variations in noncoding regions are responsible for most of the common variation heritability of the disease. It is hypothesized that these risk variants alter gene expression. Therefore, studying alterations in gene expression in schizophrenia may provide a direct approach to understanding the etiology of the disease. In this study we use cultured neural progenitor cells derived from olfactory neuroepithelium (CNON cells) as a genetically unaltered cellular model to elucidate the neurodevelopmental aspects of schizophrenia.

methodsWe performed a gene expression study using RNA sequencing of CNON cells from 111 control subjects and 144 individuals with schizophrenia. Differentially expressed genes were identified with DESeq2 software, using covariates to correct for sex, age, library batches, and 1 surrogate variable component.

resultsA total of 80 genes were differentially expressed (false discovery rate < 10%), showing enrichment in cell migration, cell adhesion, developmental process, synapse assembly, cell proliferation, and related Gene Ontology categories. Cadherin and Wnt signaling pathways were positive in overrepresentation test, and, in addition, many genes were specifically involved in WNT5A signaling. The differentially expressed genes were modestly, but significantly, enriched in the genes overlapping single nucleotide polymorphisms with genome-wide significant association from the Psychiatric Genomics Consortium genome-wide association study of schizophrenia. We also found substantial overlap with genes associated with other psychiatric disorders or brain development, enrichment in the same Gene Ontology categories as genes with mutations de novo in schizophrenia, and studies of induced pluripotent stem cell-derived neural progenitor cells.

conclusionsCNON cells are a good model of the neurodevelopmental aspects of schizophrenia and can be used to elucidate the etiology of the disorder.

Indexed as

Induced Pluripotent Stem CellsNeural Stem CellsSchizophreniaGene ExpressionGenome-Wide Association StudyHumansWnt-5a ProteinWnt-5a ProteinWNT5A protein, humanCell cultureNeural progenitorsOlfactory neuroepitheliumRNA-seqSchizophreniaWNT5A signaling

Identifiers

PMID32143829
PMCPMC10947993
OpenAlexW3001992721

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.